AquaBounty Technologies, Inc. is a leader in the field of land-based aquaculture and the use of technology for improving its productivity and sustainability. The Company's objective is to ensure the availability of high-quality seafood to meet global consumer demand, while addressing critical production constraints in the most popular farmed species.
The Company's AquAdvantage fish program is based upon a single, specific molecular modification in fish that results in more rapid growth in early development. With aquaculture facilities located in Prince Edward Island, Canada, and Indiana, USA, AquaBounty is raising its disease-free, antibiotic-free salmon in land-based recirculating aquaculture systems, offering a reduced carbon footprint and no risk of pollution of marine ecosystems as compared to traditional sea-cage farming.

Company profile
Ticker
AQB
Exchange
Website
CEO
Sylvia Wulf
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
AquaBounty Brasil Participações Ltda. • AQUA Bounty Canada Inc. • Aqua Bounty Farms Chile Limitada • AquaBounty Farms, Inc. • AquaBounty Farms Indiana LLC • AquaBounty Farms Ohio LLC ...
AQB stock data
Latest filings (excl ownership)
10-Q
2022 Q3
Quarterly report
8 Nov 22
8-K
AquaBounty Technologies Announces Third Quarter Financial Results
8 Nov 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4 Nov 22
8-K
Submission of Matters to a Vote of Security Holders
13 Oct 22
8-K
Regulation FD Disclosure
15 Sep 22
DEF 14A
Definitive proxy
31 Aug 22
PRE 14A
Preliminary proxy
19 Aug 22
8-K
Regulation FD Disclosure
11 Aug 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
8-K
AquaBounty Technologies, Inc. Announces Second Quarter 2022 Financial Results
9 Aug 22
Latest ownership filings
Financial summary
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 128.01 mm | 128.01 mm | 128.01 mm | 128.01 mm | 128.01 mm | 128.01 mm |
Cash burn (monthly) | (no burn) | (no burn) | 1.85 mm | 1.85 mm | 2.23 mm | 1.94 mm |
Cash used (since last report) | n/a | n/a | 7.94 mm | 7.98 mm | 9.60 mm | 8.36 mm |
Cash remaining | n/a | n/a | 120.07 mm | 120.03 mm | 118.41 mm | 119.65 mm |
Runway (months of cash) | n/a | n/a | 65.1 | 64.7 | 53.0 | 61.6 |
Institutional ownership, Q3 2022
27.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 69 |
Opened positions | 7 |
Closed positions | 35 |
Increased positions | 16 |
Reduced positions | 23 |
13F shares | Current |
---|---|
Total value | 15.39 mm |
Total shares | 19.71 mm |
Total puts | 171.50 k |
Total calls | 1.02 mm |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Third Security | 5.29 mm | $4.13 mm |
Vanguard | 2.62 mm | $2.05 mm |
BNP Paribas Asset Management Holding | 2.16 mm | $1.69 mm |
Epiq Partners | 1.66 mm | $1.29 mm |
BLK Blackrock | 1.24 mm | $969.00 k |
Renaissance Technologies | 801.40 k | $626.00 k |
Two Sigma Advisers | 756.90 k | $591.00 k |
Two Sigma Investments | 568.11 k | $444.00 k |
K2 Principal Fund | 559.51 k | $437.00 k |
Geode Capital Management | 507.65 k | $396.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Dec 22 | Myers Gail Sharps | Common Stock | Buy | Acquire P | No | No | 0.89 | 10,000 | 8.90 k | 10,426 |
22 Dec 22 | Myers Gail Sharps | Common Stock | Buy | Acquire P | No | No | 0.85 | 1 | 0.85 | 426 |
20 Dec 22 | Christine St.Clare | Common Stock | Buy | Acquire P | No | No | 0.7783 | 10,000 | 7.78 k | 10,000 |
19 Dec 22 | Sharp Erin S | Common Stock | Buy | Acquire P | No | No | 0.77 | 130,000 | 100.10 k | 130,000 |
19 Dec 22 | Sharp Erin S | Common Stock | Buy | Acquire P | No | No | 0.73 | 1,500 | 1.10 k | 1,500 |
16 Dec 22 | Michael K Stern | Common Stock | Buy | Acquire P | No | No | 0.74 | 20,000 | 14.80 k | 20,000 |
16 Dec 22 | Ricardo J Alvarez | Common Stock | Buy | Acquire P | No | No | 0.74 | 2,084 | 1.54 k | 2,084 |
News
$1 Million Bet On BioCardia? Check Out These 4 Penny Stocks Insiders Are Buying
21 Dec 22
12 Health Care Stocks Moving In Monday's After-Market Session
5 Dec 22
AquaBounty Technologies's Return On Capital Employed Overview
5 Dec 22
12 Health Care Stocks Moving In Friday's After-Market Session
25 Nov 22